reviewTop 1% cited
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
European Journal of Cancer · 2006 · Vol. 42(15) · pp. 2433–2453
Matti Aapro✉(Clinique de Genolier)David Cameron(Western General Hospital)Ruth Pettengell(University of London)Julia Bohlius(University of Cologne)Jeffrey Crawford(Duke Medical Center)Michael EllisNora Kearney(University of Stirling)Gary H. Lyman(University of Rochester)Vivianne C. G. Tjan‐Heijnen(Radboud University Nijmegen)Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology)Damien C. Weber(University Hospital of Geneva)C. Zielinski(Central European Cooperative Oncology Group)
Neutropenia and Cancer InfectionsBlood disorders and treatmentsPARP inhibition in cancer therapyMedicinePegfilgrastimFebrile neutropeniaChemotherapyFilgrastimNeutropeniaRegimenGranulocyte colony-stimulating factorInternal medicineIntensive care medicine
MeSH terms
Antineoplastic AgentsFemaleHumansMaleNeoplasmsNeutropeniaRecombinant ProteinsRisk FactorsGranulocyte Colony-Stimulating Factor
Funding
- Amgen
Citations
535
FWCI
25.14
field-weighted impact
References
166
Percentile
100%
vs. same field & year
Citations per year
Cited by
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
European Journal of Cancer · 2010 · 1,070 citations
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Clinical Infectious Diseases · 2011 · 3,380 citations
References
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
European Journal of Cancer · 1993 · 545 citations
Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
Annals of Internal Medicine · 1966 · 2,479 citations
A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer
JNCI Journal of the National Cancer Institute · 2003 · 1,126 citations
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
New England Journal of Medicine · 2004 · 10,930 citations
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
Clinical Infectious Diseases · 2002 · 1,972 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.